Form 4 for GILD Gilead Sciences
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-10 · accession 0001127602-23-022375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-11 | 2023-08-10 | GILD | Patterson Sandra | SVP, Controllership | F - Tax | $80.00 | -1,306 | 29.8K | -4% | -$104.5K |
| D | 2023-08-11 | 2023-08-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | +4,484 | 31.1K | +17% | — |
| D | 2023-08-11 | 2023-08-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | -4,484 | 17.6K | -20% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-10 | F | D | 1,306 | $80.00 | 29,754 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-10 | M | A | 4,484 | — | 31,060 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2023-08-10 | M | D | 4,484 | — | 17,557 | D | — · — to — | 4,484 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. |